DOI QR코드

DOI QR Code

Animal Models for the Study of Post-Micturition Dribble in Aged Male

고령 남성의 배뇨 후 요실금 연구를 위한 동물 모델

  • Seung Hwan, Jeon (Department of Clinical Laboratory Science, Suwon Science College) ;
  • Mi-Young, Park (Department of Clinical Laboratory Science, Suwon Science College)
  • 전승환 (수원과학대학교 임상병리과) ;
  • 박미영 (수원과학대학교 임상병리과)
  • Received : 2022.11.21
  • Accepted : 2022.12.08
  • Published : 2022.12.31

Abstract

Since attaining middle age, many patients suffer from the post-micturition dribble (PMD) syndrome but do not receive proper treatment. This is because the etiology and treatment mechanisms of PMD differ from conventional lower urinary tract symptoms. Several pathophysiologies have been proposed, but the mechanisms we observed are the weakening of the bulbocavernosus muscle and dilation of the urethra due to atrophy of the cavernosal tissue. This study investigates the mechanism of PMD by observing anatomical changes in the corpus cavernosum and urethra. SD male rats were categorized by age into the young rats group (8 weeks old) and the old rats group (24 months or more). The ratio area of the bulbous urethra and corpus cavernosum to the total penis was statistically significant between both groups (P<0.05). Significant differences were obtained between the two groups for restored smooth muscle contents and several other parameters related to PMD mechanisms (nNOS, α-SMA) (P<0.05). The changes in size and parameters of the urethra and corpus cavernosum in young and old rats were confirmed. The results from this study are expected to contribute to the study of PMD in the future.

중년 이후 많은 환자들이 배뇨 후 요실금을 앓고 있지만 아직 적절한 치료가 이뤄지지 않고 있다. 몇 가지 병태생리학적 기전이 제안되었지만 우리가 주목한 기전은 구해면체근과 해면체 조직의 위축으로 인한 요도의 확장이었다. 본 연구의 목적은 해면체와 요도의 해부학적 변화를 관찰하여 배뇨 후 요실금의 기전을 규명하는 것으로 8주령의 SD 수컷 랫드 그룹과 24개월 이상 된 SD 수컷 랫드 그룹으로 나누었다. 전체 음경에 대한 구부요도 및 해면체 면적의 비율은 두 그룹 간 통계적으로 유의하였다(P<0.05). 평활근 함량과 배뇨 후 요실금의 기전(nNOS, α-SMA)과 관련된 매개변수는 두 그룹 간 유의한 차이가 있었으며(P<0.05), 본 연구의 결과는 배뇨 후 요실금 연구에 기여할 것으로 기대된다.

Keywords

References

  1. Yang DY, Lee WK. A current perspective on post-micturition dribble in males. Investig Clin Urol. 2019;60:142-147. https://doi.org/10.4111/icu.2019.60.3.142
  2. Agochukwu-Mmonu N, Wiseman JB, Smith AR, Helmuth ME, Sarma AV, Cameron AP, et al. Relationship of symptom severity and bother in individuals seeking care for lower urinary tract symptoms. Neurourol Urodyn. 2020;39:2161-2170. https://doi.org/10.1002/nau.24466
  3. Choi WS, Heo NJ, Lee YJ, Son H. Factors that influence lower urinary tract symptom (LUTS)-related quality of life (QoL) in a healthy population. World J Urol. 2017;35:1783-1789. https://doi.org/10.1007/s00345-017-2052-2
  4. Hashimoto M, Shimizu N, Fujimoto S, Kuwahara K, Nishimoto M, Adomi S, et al. The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients. Int Urol Nephrol. 2022. Online ahead of print. https://doi.org/10.1007/s11255-022-03367-2
  5. Jeon SH, Shrestha KR, Kim RY, Jung AR, Park YH, Kwon O, et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology. 2016;88:226.e1-9. https://doi.org/10.1016/j.urology.2015.10.021
  6. Jung AR, Park YH, Jeon SH, Kim GE, Kim MY, Son JY, et al. Therapeutic effect of controlled release of dual growth factor using heparin-pluronic hydrogel/gelatin-poly (ethylene glycol)-tyramine hydrogel system in a rat model of cavernous nerve injury. Tissue Eng Part A. 2018;24:1705-1714. https://doi.org/10.1089/ten.TEA.2017.0469
  7. Hirahara N, Harikai S, Fujihara A, Yamada Y, Ushijima S, Ukimura O, et al. Efficacy of tadalafil on symptom-specific bother in men with lower urinary tract symptoms. Low Urin Tract Symptoms. 2022;14:393-400. https://doi.org/10.1111/luts.12457
  8. Powell T, Staib L, Liu B, Bhatia S, Chai T, Ayyagari R. Voiding and storage domain-specific symptom score outcomes after prostate artery embolization for lower urinary tract symptoms and urinary retention. Urology. 2021;156:216-224. https://doi.org/10.1016/j.urology.2021.02.046
  9. Burton CS, Gonzalez G, Vaculik K, Khalil C, Zektser Y, Arnold C, et al. Female lower urinary tract symptom prevention and treatment strategies on social media: mixed correlation with evidence. Urology. 2021;150:139-145. https://doi.org/10.1016/j.urology.2020.06.056
  10. Ito H, Young GJ, Lewis AL, Blair PS, Cotterill N, Lane JA, et al. Grading severity and bother using the international prostate symptom score and international consultation on incontinence questionnaire male lower urinary tract symptoms score in men seeking lower urinary tract symptoms therapy. J Urol. 2020;204:1003-1011. https://doi.org/10.1097/JU.0000000000001149
  11. Yang DY, Jeong HC, Ko K, Lee SH, Lee SK, Shin TY, et al. Effect of tadalafil 5 mg on post-micturition dribble in men with lower urinary tract symptoms: a multicentre, double-blind, randomized, placebo-controlled trial. BJU Int. 2019;124:862-869. https://doi.org/10.1111/bju.14849
  12. Kobayashi K, Fukuta F, Masumori N. Prevalence of post-micturition dribble in Japanese men and its relationship with benign prostatic hyperplasia/lower urinary tract symptoms. Low Urin Tract Symptoms. 2019;11:O38-O41. https://doi.org/10.1111/luts.12210
  13. Fuller TW, Ristau BT, Tepe SM, Benoit RM. Characterizing clinically meaningful changes in lower urinary tract symptoms using the American urological association symptom index. Urology. 2018;115:139-43. https://doi.org/10.1016/j.urology.2018.01.024
  14. Mpundu-Kaambwa C, Kaambwa B, Appleton S, Martin S, Wittert G, Adams R. International prostate symptom score should be considered a complement rather than a substitute to generic preference-based measures for measuring lower urinary tract symptoms within economic evaluation. Low Urin Tract Symptoms. 2018;10:45-56. https://doi.org/10.1111/luts.12140
  15. Tubaro A, De Nunzio C, Puccini F, Presicce F. The evolving picture of lower urinary tract symptom management. Eur Urol. 2015;67:271-272. https://doi.org/10.1016/j.eururo.2014.10.016
  16. Jung AR, Choi YS, Piao S, Park YH, Shrestha KR, Jeon SH, et al. The effect of PnTx2-6 protein from Phoneutria nigriventer spider toxin on improvement of erectile dysfunction in a rat model of cavernous nerve injury. Urology. 2014;84:730.e9-17. https://doi.org/10.1016/j.urology.2014.05.030
  17. Zhu GQ, Jeon SH, Bae WJ, Choi SW, Jeong HC, Kim KS, et al. Efficient promotion of autophagy and angiogenesis using mesenchymal stem cell therapy enhanced by the low-energy shock waves in the treatment of erectile dysfunction. Stem Cells Int. 2018;2018:1302672. https://doi.org/10.1155/2018/1302672
  18. Jeon SH, Bae WJ, Zhu GQ, Tian W, Kwon EB, Kim GE, et al. Combined treatment with extracorporeal shockwaves therapy and an herbal formulation for activation of penile progenitor cells and antioxidant activity in diabetic erectile dysfunction. Transl Androl Urol. 2020;9:416-427. https://doi.org/10.21037/tau.2020.01.23
  19. Jung AR, Park YH, Kim GE, Kim MY, Jeon SH, Kim HY, et al. Stem cell/oxygen-releasing microparticle enhances erectile function in a cavernous nerve injury model. Tissue Eng Part A. 2021;27:50-62. https://doi.org/10.1089/ten.TEA.2019.0240
  20. Jeong HC, Jeon SH, Guan Qun Z, Bashraheel F, Choi SW, Kim SJ, et al. Lycium chinense Mill improves hypogonadism via anti-oxidative stress and anti-apoptotic effect in old aged rat model. Aging Male. 2020;23:287-296. https://doi.org/10.1080/13685538.2018.1498079
  21. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A, et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol. 2005;173:318-323. https://doi.org/10.1097/01.ju.0000141586.46822.44
  22. Han F, Zhang S, Hou N, Wang D, Sun X. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol. 2015;309:H1501-1508. https://doi.org/10.1152/ajpheart.00443.2015